The significance of retroperitoneal lymph node dissection (RPLND) associated with radical nephrectomy for renal cell carcinoma was studied in 65 patients admitted and treated in Cancer Insitute Hospital between June 1975 and September 1985, who were divided into two groups without lymph node dissection (LND-) and with lymph node dissection (LND+).
In
(p)T classification, LND- group consisted of one patient with category
pT
1, 15 patients with category
(p)T
2, 6 with T
3 and 4 with T
4. The 3-, 5- and 10-year survival rates of 26 patients (by Kaplan-Meier's method) were 50.1, 42.9 and 26.8%, respectively.
LND+ group included one patient with category
pT
1, six with
pT
2a, 19 with
pT
2b, 7 with
pT
3 and one with
pT
4. The 3-, 5- and 10-year survival rates of 34 patients were 63.6, 48.5 and 48.5%, respectively. The prognosis became worse with higher staging.
In
(p)N classification, LND- group included 15 patients with category N
0, 3 with N
2 and one with N
3. The 3-, 5- and 10-year survival rates of N
0 group were 60.0, 50.0 and 33.3%, respectively. On the other hand, the 3-year survival rate of N+ group was 0%.
LND+ group included 21 patients with category
pN
0, two with
pN
1 and each one with
pN
2,
pN
3 or
pN
4. The 3-, 5- and 10-year survival rates of
pN
0 group were 67.5, 50.0 and 50.0%, respectively. The 3-year survival rate of
pN+ group was 40.0%.
The statistical analysis by generalized Wilcoxon test, was meaningful (p<0.025) between N
0 and N+ groups, but was not meaningful between
pN
0 and
pN+ groups. And in only two cases (5.9%) of LND+ group, RPLND was effective and meaningful.
In M classification, LND- included 11 patients with category M
0 and 20 with M+. The 3- and 5-year survival rates of M+ group were 20.0 and 0% respectively. LND+ included 21 patients with M
0 and 13 with M+ and the 3- and 5-year survival rates of M+ group were 18.5 and 0% respectively.
In
(p)V and Grade classification, the prognosis became worse with higher staging and grading.
Because, according to our results, RPLND achieved only 5.9% improvement of survival rate, the aggressive operation including RPLND and the resection of tumor emboli should be recommended for radical treatment of renal cell carcinoma. But it has a limitation from the standpoint of improvement of survival rate of renal cell carcinoma because the prognosis is dependent upon the presence of distant metastasis, mainly.
The general treatment including immunotherapy and/or chemotherapy should be developed and studied.
View full abstract